These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Optimal timing of insulin detemir injection in patients with type 1 diabetes and poor metabolic control]. Author: Segovia Portolés R, Ferrer-García JC, Merino-Torres JF, Penalba MT, Albalat Galera R, Piñón-Selles F. Journal: Endocrinol Nutr; 2010 Apr; 57(4):140-6. PubMed ID: 20347404. Abstract: AIM: To compare different administration times of insulin detemir (IDet) in patients with type 1 diabetes and poor metabolic control. MATERIAL AND METHODS: This 24-week open study included 39 people with type 1 diabetes mellitus (DM) randomized to one injection of IDet before lunch (mean 14.24 + or - 00.36 (+ or - SD) h) or at bedtime (23.19 + or - 0.42 h). Whenever target glycemia levels were not reached, the regimen was switched to insulin therapy with two injections (IDet-12h). Insulin aspart was used before main meals. RESULTS: At week 24, only 12.2% of patients remained in the IDet bedtime group and 30.3% in the IDet before lunch group. The remaining 57.5% joined the IDet-12h group. There were no differences between the IDet before lunch and IDet bedtime groups. A subanalysis including the three groups demonstrated better metabolic control in the IDet before lunch group (glycosylated hemoglobin (HbA1c) 7.1 + or - 0.2 vs. 7.6 + or - 0.4 and 8.1 + or - 0.2% in IDet before-lunch, IDet bedtime and IDet-12h, respectively; p<0.05). An HbA1c value below 7% was achieved in 30.3% of the patients: 15.2% in the IDet before-lunch group, 3.3% in the IDet bedtime group and 12.2% in IDet-12h group. Quality of life did not differ among treatment groups. CONCLUSIONS: One injection of IDet administered before lunch could improve metabolic control. However, most patients required two injections of IDet.[Abstract] [Full Text] [Related] [New Search]